CIK 0001935979 · Large accelerated filer
Biohaven Ltd.
Sign in to watch- Ticker
- BHVN
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Virgin Islands, British
- Entity type
- operating
- Phone
- 203-404-0410
- Business address
- 215 CHURCH STREET, NEW HAVEN, CT, 06510
- Former names
- Biohaven Research Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-03 | Antonijevic Irina Director | Grant or award · Stock Options (Right to Buy) | +125,000 | 125,000 | ||
| 2022-10-03 | Car Bruce Chief Scientific Officer | Grant or award · Stock Options (Right to Buy) | +300,000 | 300,000 | ||
| 2022-10-03 | Biohaven Pharmaceutical Holding Co Ltd. 10% owner | Other acquisition | +35,839,857 | 35,839,857 | ||
| 2022-10-03 | Biohaven Pharmaceutical Holding Co Ltd. 10% owner | Other disposition | −35,839,857 | 0 | ||
| 2022-10-03 | Mehta Kishan Director | Other acquisition | +5,320 | 5,320 | ||
| 2022-10-03 | Mehta Kishan Director | Other acquisition | +937 | 6,257 | ||
| 2022-10-03 | Mehta Kishan Director | Option exercise | +4,119 | $4.84 | $20K | 10,376 |
| 2022-10-03 | Mehta Kishan Director | Option exercise | +6,502 | $4.61 | $30K | 16,878 |
| 2022-10-03 | Mehta Kishan Director | Option exercise | +7,500 | $2.58 | $19K | 24,378 |
| 2022-10-03 | Mehta Kishan Director | Option exercise | +10,000 | $1.86 | $19K | 34,378 |
| 2022-10-03 | Mehta Kishan Director | Shares withheld for taxes | −11,716 | $7.00 | $82K | 22,662 |
| 2022-10-03 | Mehta Kishan Director | Other acquisition · Stock Options (Right to Buy) | +4,119 | 4,119 | ||
| 2022-10-03 | Mehta Kishan Director | Other acquisition · Stock Options (Right to Buy) | +6,502 | 6,502 | ||
| 2022-10-03 | Mehta Kishan Director | Other acquisition · Stock Options (Right to Buy) | +7,500 | 7,500 | ||
| 2022-10-03 | Mehta Kishan Director | Other acquisition · Stock Options (Right to Buy) | +10,000 | 10,000 | ||
| 2022-10-03 | Mehta Kishan Director | Option exercise · Stock Options (Right to Buy) | −4,119 | 0 | ||
| 2022-10-03 | Mehta Kishan Director | Option exercise · Stock Options (Right to Buy) | −6,502 | 0 | ||
| 2022-10-03 | Mehta Kishan Director | Option exercise · Stock Options (Right to Buy) | −7,500 | 0 | ||
| 2022-10-03 | Mehta Kishan Director | Option exercise · Stock Options (Right to Buy) | −10,000 | 0 | ||
| 2022-10-03 | Mehta Kishan Director | Grant or award · Stock Options (Right to buy) | +125,000 | 125,000 |
Page 12 of 18 · 355 trades